Evolve BioSystems Revenue and Competitors
Estimated Revenue & Valuation
- Evolve BioSystems's estimated annual revenue is currently $3.8M per year.
- Evolve BioSystems's estimated revenue per employee is $77,500
- Evolve BioSystems's total funding is $125M.
Employee Data
- Evolve BioSystems has 49 Employees.
- Evolve BioSystems grew their employee count by -28% last year.
Evolve BioSystems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP, Research & Development | Reveal Email/Phone |
3 | SVP, Marketing | Reveal Email/Phone |
4 | VP, Commercial Excellence & Clinical Implementation | Reveal Email/Phone |
5 | Director Scientific Communications | Reveal Email/Phone |
6 | Director Brand Marketing | Reveal Email/Phone |
7 | Director Information Technology | Reveal Email/Phone |
8 | Director, Medical Marketing & Professional Development | Reveal Email/Phone |
9 | Office Manager | Reveal Email/Phone |
10 | Executive Chairman and CSO | Reveal Email/Phone |
Evolve BioSystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Evolve BioSystems?
Evolve BioSystems, Inc. is a microbiome company dedicated to developing the next generation of products to establish, restore, and maintain a healthy human gut microbiome. Building on a decade of expertise in the partnership of the infant gut microbiome and breast milk components, Evolve's discovery platform is now being utilized to solve gut dysbiosis through dietary intervention throughout the human and animal life cycle. Evolve has successfully completed a milestone proof-of-concept study to demonstrate the efficacy of its initial proprietary offering and is undertaking further clinical studies to advance its pipeline of microbiome-based solutions across a spectrum of food and health applications. Social media engagement guidelines: http://www.evolvebiosystems.com/terms-and-conditions/
keywords:N/A
$125M
Total Funding
49
Number of Employees
$3.8M
Revenue (est)
-28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Evolve BioSystems News
... infantis? EVC001 (Evolve Biosystems) produced significant improvements in Bangladeshi infants with sever acute malnutrition (SAM),...
... probiotic that meets the Food and Drug Administration's good manufacturing practice guidelines and was provided by Evolve BioSystems.
and Evolve Biosystems Inc. BCD's principal scientist and co-founder is Matt Amicucci, who had previously been a postdoctoral researcher in...
DAVIS, Calif., March 11, 2021 /PRNewswire/ -- Evolve BioSystems, Inc. today announces that its product, activated B. infantis EVC001, will be used in one of the largest international clinical studies on preventing type 1 diabetes (T1D) in genetically predisposed children. The randomized, contr ...
Evolve Biosystems is an independent microbiome research company that was launched out of University of California, Davis in 2014. It was initially funded by the Bill & Melinda Gates Foundation. Also participating in the funding announced this week was investment firm Manna Tree. Evolve BioSyste ...
Other Companies in Davis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.6M | 49 | 23% | N/A |
#2 | $5.8M | 50 | N/A | N/A |
#3 | N/A | 51 | 46% | N/A |
#4 | $12.6M | 52 | 2% | N/A |
#5 | $14.1M | 54 | 4% | N/A |